These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22440861)
1. Sebaceous glands as the primary target of EGFR-inhibitors in the development of papulopustular eruption. Takata T; Tarutani M; Zouboulis CC; Sano S J Dermatol Sci; 2012 May; 66(2):165-8. PubMed ID: 22440861 [No Abstract] [Full Text] [Related]
2. Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines. Han SS; Lee M; Park GH; Bang SH; Kang YK; Kim TW; Lee JL; Chang HM; Ryu MH Br J Dermatol; 2010 Feb; 162(2):371-9. PubMed ID: 19903175 [TBL] [Abstract][Full Text] [Related]
3. Cetuximab-induced acneiform eruption and the response to isotretinoin. Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767 [No Abstract] [Full Text] [Related]
7. How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors' associated rash? Cholongitas E; Kokolakis G; Ioannidou D Int J Dermatol; 2008 Nov; 47(11):1203-4. PubMed ID: 18986464 [No Abstract] [Full Text] [Related]
9. Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: a case series and a literature review of therapeutic approaches. Nikolaou V; Stratigos A; Antoniou C; Kiagia M; Nikolaou C; Katsambas A; Syrigos K Dermatology; 2010; 220(3):243-8. PubMed ID: 20110632 [TBL] [Abstract][Full Text] [Related]
13. Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy. Chon SY; Hassler AA Br J Dermatol; 2016 Mar; 174(3):686-7. PubMed ID: 26719099 [No Abstract] [Full Text] [Related]
14. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Gencoglan G; Ceylan C Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540 [TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary team-working indicators of good practice in the clinical management of EGFR-inhibitor dermatologic toxicities. Manganoni AM; Farisoglio C; Ferrari V; Zaniboni A; Beretta G; Meriggi F; Calzavara-Pinton P Ann Surg Oncol; 2009 Jan; 16(1):224-5. PubMed ID: 18989724 [No Abstract] [Full Text] [Related]
16. Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose? Oskan F; Belka C; Manapov F Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):462-3. PubMed ID: 24074919 [No Abstract] [Full Text] [Related]
17. Successful treatment with adapalene of cetuximab-induced acneiform eruptions. Taguchi K; Fukunaga A; Okuno T; Nishigori C J Dermatol; 2012 Sep; 39(9):792-4. PubMed ID: 22168666 [No Abstract] [Full Text] [Related]
18. The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome. Lacouture ME; Lai SE Br J Dermatol; 2006 Oct; 155(4):852-4. PubMed ID: 16965448 [No Abstract] [Full Text] [Related]
19. Malassezia folliculitis presented as acneiform eruption after cetuximab administration. Cholongitas E; Pipili C; Ioannidou D J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376 [TBL] [Abstract][Full Text] [Related]
20. Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients. Bellini V; Bianchi L; Pelliccia S; Lisi P J Cutan Pathol; 2016 Mar; 43(3):211-8. PubMed ID: 26423594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]